Home › Products › Oncology › Kixta 125mg Capsule
Kixta 125mg Capsule
Salt Composition: PALBOCICLIB
- Manufacturer: ZYDUS CADILA
- Pack Size: 21 CAPSULE(s) IN A BOX
- Dosage Form: CAPSULE
- Strength: 125MG
- Prescription Required
- Storage: Keep Kixta 125 mg capsule out of sight and reach of children. Store at 20°C to 25°C.
₹3375.00₹6735.93
Inclusive of all taxes
Product Introduction
Kixta 125 mg is a targeted therapy containing palbociclib, a cyclin-dependent kinase inhibitor used in anticancer treatment. It is indicated for hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic breast cancer. The medication is administered in combination with other anticancer drugs.
Common side effects associated with Kixta 125 mg include nausea, vomiting, diarrhoea, fatigue, alopecia, dry skin, rash, infections, epistaxis, decreased appetite, low blood cell counts, oedema of lips and mouth, dysgeusia, dry eye, blurred vision, and increased lacrimation. Inform your doctor if these effects persist or cause concern.
Advise your healthcare provider of any known allergy to palbociclib or other ingredients in this capsule. Prior to commencing treatment, inform your doctor of existing conditions including signs of infection (fever, chills, sore throat), hepatic disorders, renal disorders, or sugar intolerance.
Seek immediate medical attention if you develop dry cough, chest pain, or difficulty breathing, as these may indicate pulmonary inflammation. Provide your physician with a complete list of all medications, including supplements and herbal medicines, before starting this treatment.
Effective contraception is essential during treatment and for at least three weeks after the final dose. This medication is not recommended for patients under 18 years of age.
Uses
Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.
How it works
Kixta 125 mg capsule works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.
How to Use
Take Kixta 125 mg capsule exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious: Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising) Lung inflammation (chest pain, dry cough, or difficulty breathing) Common: Tiredness Hair loss Dry skin, rash Infections Low blood cell counts Decreased of appetite Nausea, vomiting Diarrhea Swelling of lips and mouth Changes in taste Nose bleed Dry eye, blurred vision, increased tearing
Expert Tips
During Kixta 125 mg capsule treatment, it is advised to avoid grapefruit and its juices and preparations containing St. John's wort. It is recommended to use effective birth control while receiving treatment and for at least three weeks after the final dose for females and at least fourteen weeks after the final dose for males. This medication may reduce fertility, so discuss with the physician if you have any concerns. Your doctor may recommend regular blood tests to determine whether the capsule affects your blood cells.
References
- Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
- Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
- Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029
Safety Advice
Pregnancy: unsafe It is not recommended to take Kixta 125 mg capsule during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Lungs: Consult your doctor It is not unknown whether Kixta 125 mg can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe Taking a Kixta 125 mg capsule while breastfeeding is not recommended as it is not known whether it passes into the breast milk.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.